{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:26:36Z","timestamp":1793157996204,"version":"4.5.0"},"reference-count":28,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2011,1]]},"DOI":"10.1097\/mnm.0b013e328340b916","type":"journal-article","created":{"date-parts":[[2010,11,10]],"date-time":"2010-11-10T00:25:23Z","timestamp":1289348723000},"page":"37-43","source":"Crossref","is-referenced-by-count":22,"title":["Estimation of human effective absorbed dose of 67Ga\u2013cDTPA\u2013gonadorelin based on biodistribution rat data"],"prefix":"10.1097","volume":"32","author":[{"given":"Saeed","family":"Shanehsazzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsaneh","family":"Lahooti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hamid Reza","family":"Sadeghi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amir Reza","family":"Jalilian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-6-20210212","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/S0969-8043(02)00311-1","article-title":"Pharmacokinetics and radiation dosimetry estimation of O-(2-18F fluoroethyl)-l-tyrosine as oncologic PET tracer.","volume":"58","author":"Tang","year":"2003","journal-title":"Appl Radiat Isot"},{"key":"R2-6-20210212","first-page":"1805","article-title":"Synthesis and evaluation of (18) F-labeled choline analogs as oncologic PET tracers.","volume":"42","author":"DeGrado","year":"2001","journal-title":"J Nucl Med"},{"key":"R3-6-20210212","first-page":"307","article-title":"Biodistribution and dosimetry of carbon-11-methoxyprogabidic acid, a possible ligand for GABA-receptors in the brain.","volume":"39","author":"Santens","year":"1998","journal-title":"J Nucl Med"},{"key":"R4-6-20210212","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1093\/rpd\/ncp085","article-title":"Determination of human absorbed dose of 67GA-DTPA-ACTH based on distribution data in rats.","volume":"134","author":"Shanehsazzadeh","year":"2009","journal-title":"Radiat Prot Dosimetry"},{"key":"R5-6-20210212","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10967-007-7241-9","article-title":"Preparation and evaluation of 67Ga-DTPA-gonadorelin in normal rats.","volume":"278","author":"Jalilian","year":"2008","journal-title":"J Radioanal Nucl Chem"},{"key":"R6-6-20210212","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/0006-291X(71)90766-2","article-title":"Isolation and properties of the FSH and LH-releasing hormone.","volume":"43","author":"Santens","year":"1971","journal-title":"Biochem Biophys Res Commun"},{"key":"R7-6-20210212","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/joe.0.1200011","article-title":"Gonadotropin releasing hormone: its action and receptors.","volume":"120","author":"Clayton","year":"1989","journal-title":"J Endocrinol"},{"key":"R8-6-20210212","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1530\/eje.0.1510619","article-title":"Gonadotropin-releasing hormone (GnRH) agonist Triptorelin inhibits estradiol-induced serum response element (SRE) activation and c-fos expression in human endometrial, ovarian and breast cancer cells.","volume":"151","author":"Grundker","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"R9-6-20210212","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/er.2003-0002","article-title":"Gonadotropin-releasing hormone receptors.","volume":"25","author":"Millar","year":"2004","journal-title":"Endocr Rev"},{"key":"R10-6-20210212","doi-asserted-by":"crossref","first-page":"257","DOI":"10.2174\/156800906776842966","article-title":"Gonadotropin-releasing hormone (GnRH) receptors in tumors: a new rationale for the therapeutical application of GnRH analogs in cancer patients.","volume":"6","author":"Marelli","year":"2006","journal-title":"Curr Cancer Drug Targets"},{"key":"R11-6-20210212","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1210\/en.2004-1481","article-title":"Bifunctional gonadotropin-releasing hormone antagonist-progesterone analogs with increased efficacy and duration of action.","volume":"147","author":"Ratcliffe","year":"2006","journal-title":"Endocrinology"},{"key":"R12-6-20210212","doi-asserted-by":"crossref","first-page":"12495","DOI":"10.1073\/pnas.0504163102","article-title":"Antagonists of growth hormone-releasing hormone cross the blood-brain barrier: a potential applicability to treatment of brain tumors.","volume":"102","author":"Jaeger","year":"2005","journal-title":"Proc Natl Acad Sci U S A"},{"key":"R13-6-20210212","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S0969-8043(99)00209-2","article-title":"Decay scheme of 67Ga.","volume":"52","author":"Simpson","year":"2000","journal-title":"Appl Radiat Isot"},{"key":"R17-6-20210212","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1089\/cbr.2005.20.126","article-title":"Establishing a clinically meaningful predictive model of hematologic toxicity in nonmyeloablative targeted radiotherapy: practical aspects and limitations of red marrow dosimetry.","volume":"20","author":"Siegel","year":"2005","journal-title":"Cancer Biother Radiopharm"},{"key":"R18-6-20210212","first-page":"248","article-title":"Radiation dosimetry of 131I-19-Iodocholesterol: the pitfalls of using tissue concentration data - reply.","volume":"16","author":"Kirschner","year":"1975","journal-title":"J Nucl Med"},{"key":"R22-6-20210212","first-page":"1","article-title":"The 2007 Recommendations of the International Commission on Radiological Protection. International Commission on Radiological Protection, ICRP Publication103.","volume":"37","year":"2007","journal-title":"Ann ICRP"},{"key":"R23-6-20210212","first-page":"92","article-title":"Pharmacokinetics and radiation dosimetry of 18F-fluorocholine.","volume":"43","author":"DeGrado","year":"2002","journal-title":"J Nucl Med"},{"key":"R24-6-20210212","first-page":"634","article-title":"Pharmacokinetics and biodistribution of 111In- and 177Lu-labeled J591 antibody specific for prostate-specific membrane antigen: prediction of 90Y-J591 radiation dosimetry based on 111In or 177Lu.","volume":"46","author":"Vallabhajosula","year":"2005","journal-title":"J Nucl Med"},{"key":"R25-6-20210212","first-page":"1555","article-title":"Biodistribution and radiation dosimetry of the serotonin transporter ligand 11C-DASB determined from human whole-body PET.","volume":"45","author":"Lu","year":"2004","journal-title":"J Nucl Med"},{"key":"R26-6-20210212","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/S0969-8051(02)00316-5","article-title":"In vitro and in vivo characterization of 11C-DASB: a probe for in vivo measurements of the serotonin transporter by positron emission tomography.","volume":"29","author":"Wilson","year":"2002","journal-title":"Nucl Med Biol"},{"key":"R27-6-20210212","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00006231-200401000-00012","article-title":"Radiation dosimetry estimates for the PET serotonin transporter probe 11C-DASB determined from whole-body imaging in non-human primates.","volume":"25","author":"Tipre","year":"2004","journal-title":"Nucl Med Commun"},{"key":"R28-6-20210212","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/108497803322287682","article-title":"Biodistribution and dosimetry of 177Lu-labeled DOTA0,Tyr3octreotate in male nude mice with human small cell lung cancer.","volume":"18","author":"Schmitt","year":"2003","journal-title":"Cancer Biother Radiopharm"},{"key":"R29-6-20210212","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1002\/1097-0215(20010601)92:5<628::AID-IJC1244>3.0.CO;2-L","article-title":"177Lu-DOTA0, Tyr3 octreotate for somatostatin receptor-targeted radionuclide therapy.","volume":"1","author":"De Jong","year":"2001","journal-title":"Int J Cancer"},{"key":"R30-6-20210212","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1002\/ijc.1540","article-title":"Toxicity and dosimetry of 177Lu-DOTA-Y3-octreotate in a rat model.","volume":"94","author":"Lewis","year":"2001","journal-title":"Int J Cancer"},{"key":"R31-6-20210212","first-page":"1148","article-title":"Pharmacokinetics and Biodistribution of (86)Y-Trastuzumab for (90)Y dosimetry in an ovarian carcinoma model: correlative MicroPET and MRI.","volume":"44","author":"Palm","year":"2003","journal-title":"J Nucl Med"},{"key":"R32-6-20210212","first-page":"376","article-title":"Biodistribution and radiation dosimetry of the dopamine transporter ligand.","volume":"42","author":"Deterding","year":"2001","journal-title":"J Nucl Med"},{"key":"R33-6-20210212","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1097\/MNM.0b013e3283060c72","article-title":"Biodistribution and radiation dosimetry of 18F F-PEB in nonhuman primates.","volume":"29","author":"Belanger","year":"2008","journal-title":"Nucl Med Commun"},{"key":"R34-6-20210212","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1007\/s11307-008-0160-5","article-title":"Radiation dose estimates for (18) F 5-fluorouracil derived from pet-based and tissue-based methods in rats.","volume":"10","author":"Kesner","year":"2008","journal-title":"Mol Imaging Biol"}],"container-title":["Nuclear Medicine Communications"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.ovid.com\/00006231-201101000-00006","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T18:40:07Z","timestamp":1786041607000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/00006231-201101000-00006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1]]},"references-count":28,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2011]]}},"URL":"https:\/\/doi.org\/10.1097\/mnm.0b013e328340b916","relation":{},"ISSN":["0143-3636"],"issn-type":[{"value":"0143-3636","type":"print"}],"subject":[],"published":{"date-parts":[[2011,1]]}}}